Chelation of charged and uncharged molecules with...

Chemistry: analytical and immunological testing – Heterocyclic carbon compound

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C436S073000, C436S096000, C540S145000, C514S064000, C514S185000, C514S397000, C514S410000

Reexamination Certificate

active

10712513

ABSTRACT:
Porphyrins containing one or more neutral or negatively-charged, closo- or nido-carborane substituents are useful as chelators. The carbon-carbon bonds linking the boron-containing groups to the porphyrin ring make the compounds highly resistant to hydrolysis. These compounds have potential for use in selective binding to specific ligands. These compounds are highly stable, soluble in water and organic solvents, and have low toxicity.

REFERENCES:
patent: 4959356 (1990-09-01), Miura et al.
patent: 5284831 (1994-02-01), Kahl et al.
patent: 5877165 (1999-03-01), Miura et al.
patent: 5955586 (1999-09-01), Sessler et al.
patent: 6566517 (2003-05-01), Miura et al.
patent: 6759403 (2004-07-01), Miura et al.
patent: 6951640 (2005-10-01), Miura et al.
patent: 7067653 (2006-06-01), Vicente et al.
patent: WO 01/85736 (2001-11-01), None
Barth, R. et al., “Boron Neutron Capture Therapy of Brain Tumors: An Emerging Therapeutic Modality,”Neurosurg., vol. 44, No. 3, pp. 433-451 (1999).
U.S. Appl. No. 60/426,612, filed Nov. 15, 2002, Vicente.
U.S. Appl. No. 60/426,062, filed Nov. 13, 2002, Vicente et al.
Allen, W. et al., “Binding of neutral substrates by calix[4]pyrroles,”J. Am. Chem. Soc., vol. 118, pp. 12471-12472 (1996).
Dougherty, T. et al., “Photodynamic Therapy,”J. Natl. Cancer Inst., vol. 90, pp. 889-905 (1998).
Gale, P. et al., “Calix[4]pyrroles: old yet new anion-binding agents,”J. Am. Chem. Soc., vol. 118, pp. 5140-5141 (1996).
Hsi, R. et al., “Photodynamic Therapy in the Treatment of Cancer. Current State of the Art,”Drugs, vol. 57, pp. 725-734 (1999).
Lauceri, R. et al., “Interactions of Anionic Caboranylated Porphyrins with DNA,”J. Am. Chem. Soc., vol. 123, pp. 5835-5836 (2001).
Madema, A. et al., “Synthesis of a porphyrin-labelled carboranyl phosphate diester: a potential new drug for boron neutron capture therapy of cancer,”Chem. Commun., pp. 1784-1785 (2002).
Sessler, J. et al., “Anion binding: a new direction in porphyrin-related research,”Pure&Appl. Chem., vol. 65, pp. 393-398 (1993).
Sessler, J. et al., “Anion binding: self-assembly of polypyrrolic macrocycles,”Angew. Chem. Int. Ed. Engl., vol. 35, pp. 2782-2785 (1996).
Vicente, M. et al., “First Structural Characterization of a Covalently Bonded Porphyrin-Carborane System,”Chem. Commun., pp. 483-484 (2001).
Vicente, M., “Porphyrin-based sensitizers in the dectection and treatment of cancer: recent progress,”Curr. Med. Chem., vol. 1, pp. 175-194 (2001).
Vicente, M. et al., “Syntheses and preliminary biological studies of fourmeso-tetra[(nido-carboranylmethyl)phenyl]prophyrins,”Bioorganic&Medicianl Chem., vol. 10, pp. 481-492 (2002).
Vicente, M. et al., “Syntheses of carbon-carbon linked carboranylated porphyrins for boron neutron capture therapy of cancer,”Tetr. Lett., vol. 41, pp. 7623-7627 (2000).
Vicente, M. et al., “Synthesis, dark toxicity and induction of in vitro DNA photodamage by a tetra(4-nido-carboranyl)porphyrin,”J. Photochemistry and Photobiology, vol. 68, pp. 123-132 (2002).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Chelation of charged and uncharged molecules with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chelation of charged and uncharged molecules with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chelation of charged and uncharged molecules with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3762975

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.